Frazier Healthcare, a provider of growth capital to healthcare companies, announces that
Tadataka Yamada has re-joined Frazier Healthcare, a provider of growth capital to healthcare companies. He will serve as a Venture Partner on the Life Sciences team, focusing on creating companies as well as providing strategic guidance to existing portfolio companies.
He will also serve as a Senior Advisor to the Growth Buyout team, where he will provide advice on opportunities in pharmaceutical services and spin-outs from large healthcare companies, and sit on boards of portfolio companies such as PCI, a large pharmaceutical services company in the Frazier portfolio.
“Tachi’s experiences and insight into the rapidly-changing healthcare world will be invaluable to our theme-based investing strategy,” says Chairman Alan Frazier. Managing General Partner Jamie Topper added, "I am thrilled that Tachi is re-joining our Life Sciences team at Frazier. His extensive experience in all aspects of drug development will once again be a tremendous addition to our investing team.”
Before re-joining Frazier, Dr Yamada was Chief Medical and Scientific Officer at Takeda Pharmaceuticals in Tokyo, as well as a member of the Board of Directors. In this role, Dr Yamada was responsible for all of Takeda’s research & development activities, with a budget of nearly USD4 billion.
Prior to Takeda, Dr Yamada was President of the Bill & Melinda Gates Foundation Global Health Program in Seattle, where he oversaw over $9 billion in grants for applying technologies to address major health challenges of the developing world. Before joining the Gates Foundation, Dr Yamada was Chairman of Research and Development at GlaxoSmithKline and a member of the board of directors. Earlier, Dr Yamada was the Chief of the Division of Gastroenterology and the Chair of the Department of Internal Medicine at the University of Michigan in Ann Arbor.
In addition to his role at Frazier, Dr Yamada serves as a member of the board of directors at the Clinton Health Access Initiative and of the Council of the Institute of Medicine of the National Academy of Sciences. He is also a Fellow of the Imperial College of Medicine, a Master of the American College of Physicians, a Fellow of the Royal College of Physicians, and a past-President of the American Gastroenterological Association and the Association of American Physicians.
